sofwave neck skin firmness glp-1 drugs Weight Loss: Addressing Sagging with Improving Aesthetic Results for GLP-1

As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act

What This Means Practically For patients with Type 2 diabetes, these findings have practical implications: First-line treatment recommendation: Major diabetes guidelines now recommend GLP-1 agonists as first-line treatment (alongside or instead of metformin) for patients with established cardiovascular disease

Supports sleep-linked recovery circuitry

is an area of future research

The same applies to cancers such as breast, ovarian, uterine, pancreatic, and esophageal cancer, among others